Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve Intimation of Board meeting to be held on May 26, 2025 to consider Audited Financial Results for the fourth quarter and financial year ended March 31, 2025.